| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f953e662f0f4a6aedb6f11302833d60 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2511-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-13009 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-13009 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 |
| filingDate |
2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a0f6f5c2357f658bfa2795167a650e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1eefd5202c0f3a7f3c244871725124e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58ca728fb0b0e3ef7799765d99c26d3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79a266f02a3fc5ce8e6af4b426bfb828 |
| publicationDate |
2018-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180044029-A |
| titleOfInvention |
Prolidase mutant, and preparation method and use thereof |
| abstract |
The present invention relates to a pyrrolidase mutant through the amino acid substitution of an organic phosphoric acid hydrolase, Prolidase, a method for preparing the same, and the use of the pyrrolidase mutant prepared as described above, More particularly, the present invention relates to a method for the detection of a follidase mutation in which the amino acid of the 252 th residue or the amino acid of the 365 th residue is substituted with arginine from the N-terminus of the follidylase through a database-based in silico analysis And a recombinant expression vector containing the corresponding prolylderase mutant gene, a prokaryotic cell transformed from the recombinant expression vector, and a method for producing a prolylase mutant using the same, and a method for producing a wild- Lt; RTI ID = 0.0 > of frolidase < / RTI > As a solvent for the active inhibitory composition to inhibit the poisoning symptoms of nerve agents there is an effect that can be applied to prevention and treatment of nerve agents. |
| priorityDate |
2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |